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Results: Three hundred and seven CAS patients were
identified, of which 190 were considered high-risk (62%),
101 were physiologically high-risk (53%), 63 were anatom-
ically high-risk (33%), and 26 were both (14%). Ninety-six
patients were symptomatic (31%). Twenty-three patients
suffered complications (7.5%), including 9 CVAs (2.9%), 8
TIAs (2.6%), 4 MIs (1.3%), and 4 deaths (1.3%). Indepen-
dent predictors of CVA/TIA, death, or MI were physio-
logic high-risk status, symptomatic status, andmale gender,
while anatomic high-risk status was not (Table 1).
Conclusions: Current CMS physiologic high-risk
CEA criteria place patients at increased risk for adverse
events for CAS. This warrants the need for improved pa-
tient selection criteria for CAS vs. CEA in physiologically
high-risk patients.
Table 1. Results of multivariate logistic regression
analysis
OR CI p-Value
HR (Physiologic) 2.54 1.01-6.42 0.047
HR (Anatomic) 1.02 0.39-2.67 0.96
Symptomatic 3.77 1.54-9.26 0.004
Male Gender 3.22 1.04-9.95 0.042
HR, high-risk; OR, odds ratio; CI, confidence interval.
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Objectives: Cerebral hyperperfusion syndrome (CHS)
following carotid endarterectomy (CEA) is defined by a
combination of symptoms and at least a doubling of pre-
operative cerebral blood flow, correlated to a doubling of
the mean blood velocity (Vmean) measured in the ipsilat-
eral middle cerebral artery with transcranial Doppler
(TCD). Currently, an increase in Vmean of 100% 3
minutes after carotid declamping, compared to pre-clamp-
ing Vmean is the gold standard for CHS prediction. How-
ever, applying this method, not all patients at risk for CHS
are identified, while others may be treated unnecessarily.
We hypothesize that the positive predictive value (PPV) of
TCD in the prediction of CHS can be increased by an
additional post-operative TCD measurement within two
hours after CEA.
Methods: In 184 CEA patients the pre-operative (V1),
pre-clamping (V2), post-clamping (V3) and post-operative
Vmean (V4) was measured by TCD and standard blood
pressures were scored. The intra-operative Vmean increase
((V3 - V2) / V2) was compared to the post-operative
increase ((V4 - V1 )/ V1) in relation to CHS and post-
operative hypertension. Outcome was reported as PPV and
ROC-curve analysis.
Results: An intra-operative Vmean increase of 100%
was noted in 16 patients (9%), and a post-operative Vmean
increase in 22 (12%) patients. In 10 patients (5%) CHS was
diagnosed; two of those had an intra-operative Vmean
increase of 100% and nine a post-operative Vmean in-
crease 100%. This results in a PPV of 13% for the intra-
operative and 41% for the postoperative measurement, and
a PPV of 29% if both measurements were combined.
ROC curve analysis showed an area under the curve of
0.641 for the intra-operative and 0.904 for the post-oper-
ative Vmean measurement method.
Conclusions: A post-operative Vmean increase of
100% as measured by TCD is superior to both the intra-
operative and the combined intra- and post-operative TCD
measurement for the identification of patients at risk for the
development of CHS after CEA.
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Objectives: Cost-effectiveness has become an impor-
tant endpoint in comparing therapies considered to have
clinical equipoise. Prior economic analysis of carotid artery
treatment has been limited by small sample size.
Methods: A retrospective analysis of hospital cost and
30 day clinical outcomes was performed on patient under-
going carotid endarterectomy (CEA) and carotid stenting
with (CAS) between 1/1/08 - 9/30/10 at a single insti-
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tution. Cost (not charges) of the index hospitalization
included direct and indirect costs and was normalized to
2010 values. Data are mean /- S.D.
Results: 306 patients underwent either CEA (n174)
or CAS (n132). Patients undergoing CEA trended to-
wards a higher prevalence of being symptomatic (44.8
%)compared to CAS(34.0%,P 0.09). Age was not signif-
icantly different between patients undergoing CEA and
CAS (70.2 vs 72.0,respectively, P0.36). CAD was more
common in patients undergoing CAS (60.3% vs
39%,P0.003). The prevalence of COPD, ESRD, Hyper-
tension and diabetes were not significantly significant.
Mean hospital cost for CAS was $9426/5776 while
CEA cost was $6734/3935 (P  0.0001). This cost
differential was driven by the higher direct supply costs for
CAS ($5634) vs CEA ($1967),(P  .0001). These
higher costs for CAS were seen consistently in symptom-
atic, asymptomatic, elective and urgent subgroups (Table).
30 day stroke/death/MI rate was 2.3%(4/174)in the CEA
group and 3.8%(5/132) in the CAS group,P0.5. Overall
LOS was 2.1 days in both groups (P0.9).
N
Length of
Stay (days) Cost ($) P
CAS CEA CAS CEA CAS CEA
Entire Cohort 132 174 2.1 2.06 9426 6734 0.0001
Symptomatic 45 78 3.5 2.85 12128 7750 0.0001
Asymptomatic 87 96 1.3 1.43 7983 5835 0.0068
Elective 118 152 1.4 1.34 8538 5841 0.0001
Urgent 14 22 7.5 7.05 16095 12540 0.0542
Conclusions: Treatment of carotid artery disease with
CAS was 40% more costly than CEA and did not provide
better clinical outcomes or a reduction in LOS. The cost
differential was driven entirely by the increased supply costs
in the CAS cohort. At present, carotid stenting cannot be
considered a cost-effective treatment for carotid artery
disease.
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Objectives: To analyze early and long term results of
endovascular infrainguinal peripheral revascularizations in
female patients in a single centre experience.
Methods: From January 2000 to March 2010, 223
consecutive endovascular interventions for femoro-popli-
teal disease in 214 patients were performed. Interventions
were performed in females in 71 cases (group 1) and in
males in 152 cases (group 2).
Early and follow-up results were analyzed and com-
pared with appropriate statistical tests.
Results: There were no differences between the two
groups in terms of risk factors for atherosclerosis, comor-
bidities, clinical status, TASC II classification of arterial
lesions and technical characteristics of the procedures.
Technical failure rate was 3.9% in group 2, while no
failure occurred in group 1 (p0.09).
Cumulative 30-day mortality was 0.9%, with no differ-
ence between females (no deaths) and males (2 deaths,
1.3%; p0.3). Overall amputation rate at 30 days was 1.3%,
again with no differences between the two groups (2.8%
and 0.7%, respectively; p0.2); also the rate of periopera-
tive thrombosis (overall 2.7%) was similar between the two
groups (2.8% and 2.6%, respectively; p0.4).
Follow-up was available in 95 % of patients with a mean
duration of 17 months (range 1-85).
Estimated 36-month survival rates were 95% in group 1
and 81.8% in group 2 (p0.3; log-rank 0.9). Primary,
assisted primary and secondary patency rates at 36 months
were 39.8%, 49.1% and 62% in group 1 and 41.3%, 55.5%
and 75% in group 2, without significant differences be-
tween the two groups. Also the rates of freedom from any
(open or endovascular) reintervention and from conversion
to surgical bypass at 3 years were similar. In patients with
critical limb ischemia, limb salvage rates at 36 months were
80.5% and 90.3, respectively (p0.7, log-rank 0.2).
Conclusions: Endovascular treatment of femoro-pop-
liteal occlusive disease provides similar results between
males and females at an intermediate follow-up.
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Objectives: Cardiac risk factors encompassed in the
Revised Cardiac Risk (RCR) index help identify patients at
the highest cardiac risk in the surgical population. Recently,
high-sensitivity C-reactive protein (hs-CRP), the common
JOURNAL OF VASCULAR SURGERY
Volume 53, Number 17S Abstracts 55S
